Doximity, Inc.
DOCS · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $10,842 | $5,022 | $6,255 | $8,516 |
| - Cash | $210 | $97 | $158 | $113 |
| + Debt | $12 | $15 | $16 | $1 |
| Enterprise Value | $10,645 | $4,940 | $6,113 | $8,404 |
| Revenue | $570 | $475 | $419 | $344 |
| % Growth | 20% | 13.5% | 22% | – |
| Gross Profit | $515 | $425 | $366 | $304 |
| % Margin | 90.2% | 89.3% | 87.2% | 88.4% |
| EBITDA | $241 | $182 | $135 | $119 |
| % Margin | 42.2% | 38.3% | 32.3% | 34.5% |
| Net Income | $223 | $148 | $113 | $155 |
| % Margin | 39.1% | 31% | 26.9% | 45.1% |
| EPS Diluted | 1.11 | 0.72 | 0.53 | 0.7 |
| % Growth | 54.2% | 35.8% | -24.3% | – |
| Operating Cash Flow | $273 | $184 | $180 | $127 |
| Capital Expenditures | -$7 | -$6 | -$6 | -$6 |
| Free Cash Flow | $267 | $178 | $173 | $121 |